Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Therapie
|
November 1, 2012
Monoclonal Antibodies for Therapeutic Use: Specific Characteristics of Clinical Development, Evaluation by the Agencies, and Long-term Monitoring of Safety
Gilles Paintaud, Marine Diviné, Philippe Lechat, et al.
Therapie
|
April 16, 2016
Clinical research and methodology: What usage and what hierarchical order for secondary endpoints?
Silvy Laporte, Marine Diviné, Danièle Girault, et al.
Therapie
|
November 1, 2012
[In Process Citation]
Gilles Paintaud, Marine Diviné, Philippe Lechat, et al.
Therapie
|
July 10, 2016
[Not Available]
Gilles Paintaud, Marine Diviné, Philippe Lechat, et al.
Acta Haematologica
|
January 19, 2013
Failure of fluorodeoxyglucose positron emission tomography to detect the high-grade transformation of nodular lymphocyte predominant Hodgkin's lymphoma
Mathieu Puyade, Mokrane Yacoub, Cécile Tomowiak, et al.
Cancer
|
December 24, 2009
Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group
Irene Biasoli, Aspasia Stamatoullas, Véronique Meignin, et al.
British Journal of Haematology
|
February 19, 2002
Severe decrease in peripheral blood dendritic cells in hairy cell leukaemia
Anne Bourguin-Plonquet, Hélène Rouard, Françoise Roudot-Thoraval, et al.
Leukemia & Lymphoma
|
April 25, 2007
A weekly regimen with dose escalation of doxorubicin for patients with advanced Hodgkin's lymphoma: results of a phase II study of the Groupe d'Etudes des Lymphomes de l'Adulte (GELA)
Christophe Fermé, Pauline Brice, Anne-Sophie Michallet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 12, 2002
Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial
Christophe Fermé, Nicolas Mounier, Marine Diviné, et al.
Anti-Cancer Drugs
|
May 31, 2008
A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients
Patricia Validire, Christophe Fermé, Pauline Brice, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Therapie
|
November 1, 2012
Monoclonal Antibodies for Therapeutic Use: Specific Characteristics of Clinical Development, Evaluation by the Agencies, and Long-term Monitoring of Safety
Gilles Paintaud, Marine Diviné, Philippe Lechat, et al.
Therapie
|
April 16, 2016
Clinical research and methodology: What usage and what hierarchical order for secondary endpoints?
Silvy Laporte, Marine Diviné, Danièle Girault, et al.
Therapie
|
November 1, 2012
[In Process Citation]
Gilles Paintaud, Marine Diviné, Philippe Lechat, et al.
Therapie
|
July 10, 2016
[Not Available]
Gilles Paintaud, Marine Diviné, Philippe Lechat, et al.
Acta Haematologica
|
January 19, 2013
Failure of fluorodeoxyglucose positron emission tomography to detect the high-grade transformation of nodular lymphocyte predominant Hodgkin's lymphoma
Mathieu Puyade, Mokrane Yacoub, Cécile Tomowiak, et al.
Cancer
|
December 24, 2009
Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group
Irene Biasoli, Aspasia Stamatoullas, Véronique Meignin, et al.
British Journal of Haematology
|
February 19, 2002
Severe decrease in peripheral blood dendritic cells in hairy cell leukaemia
Anne Bourguin-Plonquet, Hélène Rouard, Françoise Roudot-Thoraval, et al.
Leukemia & Lymphoma
|
April 25, 2007
A weekly regimen with dose escalation of doxorubicin for patients with advanced Hodgkin's lymphoma: results of a phase II study of the Groupe d'Etudes des Lymphomes de l'Adulte (GELA)
Christophe Fermé, Pauline Brice, Anne-Sophie Michallet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 12, 2002
Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial
Christophe Fermé, Nicolas Mounier, Marine Diviné, et al.
Anti-Cancer Drugs
|
May 31, 2008
A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients
Patricia Validire, Christophe Fermé, Pauline Brice, et al.
Page
of 2